认知偏差矫正干预对焦虑和抑郁障碍疗效的系统综述与网络Meta分析
该系统综述与网络Meta分析纳入85项随机对照试验(焦虑65项n=3897,抑郁20项n=1116),评估认知偏差矫正(CBM)对成人临床或亚临床焦虑抑郁症状的疗效。
要点
- 解释偏差矫正对焦虑症状优于等待名单和假训练,效应量小至中等。
- 注意偏差矫正仅在排除创伤后应激障碍试验的事后敏感性分析中显示获益。
- 抑郁试验网络存在不一致性,且仅4项试验所有6个领域低偏倚风险。
核心结论
- CBM干预显示一致但较小的获益,异质性和偏倚风险削弱了 findings 的可靠性。
- 焦虑的解释偏差矫正可能需要更大规模的确证性试验,抑郁证据不足无法得出结论。
研究设计与样本
- 系统综述与网络Meta分析,检索PubMed、PsycINFO、Embase和Cochrane Central从建库至2020年2月7日。
- 纳入比较CBM与对照或其他CBM的随机对照试验,对象为18岁及以上临床或亚临床焦虑或抑郁成人。
- 排除CBM与非CBM主动干预比较的研究,两名研究者独立筛选并采用Cochrane工具评估偏倚风险。
- 从2125条记录中纳入85项试验,焦虑65项(n=3897),抑郁20项(n=1116)。
主要发现
- 注意偏差矫正仅在排除创伤后应激障碍试验的事后敏感性分析中显示获益。
- 所有发现的预测区间较大,包括SMD为0。
- 抑郁试验网络显示不一致性证据,仅4项随机对照试验在评估的6个领域均低偏倚风险。
关键数值与推荐
- 主要结局为采用验证性临床量表测量的焦虑和抑郁症状。
- 采用限制最大似然随机效应模型计算标准化均数差(SMD)。
临床怎么用
- 解释偏差矫正对焦虑症状有小幅获益,可考虑作为辅助干预,但需注意证据异质性。
- 注意偏差矫正对焦虑的获益仅在排除PTSD试验后出现,临床应用需谨慎选择人群。
- 抑郁的CBM证据不足,暂不支持常规临床推荐。
局限性
- 异质性和偏倚风险 undermining findings 的可靠性。
- 所有发现的预测区间较大,包括SMD为0。
- 抑郁试验网络存在不一致性证据。
- 仅4项随机对照试验在评估的6个领域均低偏倚风险。
- 排除CBM与非CBM主动干预比较的研究,可能限制结论外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cognitive bias modification (CBM) therapies, including attention bias modification, interpretation bias modification, or approach and avoidance training, are prototypical examples of mechanistically derived treatments, but their effectiveness is contentious. We aimed to assess the relative effectiveness of various CBM interventions for anxious and depressive symptomatology. METHODS: For this systematic review and network meta-analysis, we searched PubMed, PsycINFO, Embase, and Cochrane Central Register from database inception up until Feb 7, 2020. We included randomised controlled trials of CBM versus control conditions or other forms of CBM for adults aged 18 years and older with clinical or subclinical anxiety or depression measured with a diagnostic interview or a validated clinical scale. We excluded studies comparing CBM with a non-CBM active intervention. Two researchers independently selected studies and evaluated risk of bias with the Cochrane Collaboration tool. Primary outcomes encompassed anxiety and depressive symptoms measured with validated clinical scales. We computed standardised mean differences (SMDs) with a restricted maximum likelihood random effects model. This study is registered with PROSPERO, CRD42018086113. FINDINGS: From 2125 records we selected 85 trials, 65 (n=3897) on anxiety and 20 (n=1116) on depression. In a well connected network of anxiety trials, interpretation bias modification outperformed waitlist (SMD -0·55, 95% CI -0·91 to -0·19) and sham training (SMD -0·30, -0·50 to -0·10) for the primary outcome. Attention bias modification showed benefits only in post-hoc sensitivity analyses excluding post-traumatic stress disorder trials. Prediction intervals for all findings were large, including an SMD of 0. Networks of depression trials displayed evidence of inconsistency. Only four randomised controlled trials had low risk of bias on all six domains assessed. INTERPRETATION: CBM interventions showed consistent but small benefits; however heterogeneity and risk of bias undermine the reliability of these findings. Larger, definitive trials for interpretation bias modification for anxiety might be warranted, but insufficient evidence precludes conclusions for depression. FUNDING: Romanian Ministry of Research and Innovation, The National Council for Scientific Research-The Executive Agency for Higher Education, Research, Development and Innovation Funding.
引用
- Fodor LA, Georgescu R, Cuijpers P, et al. Efficacy of cognitive bias modification interventions in anxiety and depressive disorders: a systematic review and network meta-analysis. Lancet Psychiatry. 2020. PMID: 32445689. doi:10.1016/S2215-0366(20)30130-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。